In a report released today, Akash Tewari from Jefferies maintained a Buy rating on Eli Lilly & Co (LLY – Research Report), with a price ...

We recently compiled a list of the Billionaire Ken Fisher’s Top 15 Stock Picks Heading Into 2025. In this article, we are ...

Analyst Terence Flynn from Morgan Stanley maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) and increased the price target ...

Unless you have been living under a rock, you’ll know that anti-obesity GLP-1 drugs are the next big thing in pharma, with ...

Dr. Oz has extolled Ozempic’s promise for weight-loss. Now Medicare, which Trump wants Oz to oversee, may cover it.

Jaguar's rebranding marks a radical identity shift for the carmaker. One ad expert called it "bonkers." Others said it was a successful disruption.

It’ll be a busy December for dividend growth investors, with 25 companies announcing their annual increases. Check out the ...

The obesity duopoly has been pierced as Amgen positions itself to have a drug on the market in a few years. While this adds ...

Now, Lilly Downs is living life outside the hospital’s walls, on her own for the first time, traveling with friends to Utah, ...

Gov. Eric Holcomb said Clay Robbins' "humble service to our great state truly represents the very best of what it means to be ...

A new class of weight-loss drugs touted as a revolutionary breakthrough in obesity management have received global attention, ...

After 10 long years, the company that has developed a collagen biomaterial to help heal tissue is readying itself for its ...